The Effect of Smoking in Bladder Cancer Patients | News Brief

An international investigation has found that cumulative smoking history appears to be an independent risk factor for non-muscle invasive bladder cancer recurrence and progression. When compared with current smoking, cessation of more than 10 years before treatment was shown to decrease the risk of disease recurrence.

Abstract: Journal of Urology, December 2012.


From our CME partner, AKH Inc.

CME: On the Spot Oncology
CME Credit: .25 hour activities

While several aspects of therapy for patients with gastroenteropancreatic neuroendocrine tumors (GEP-NETs) have remained unchanged for several decades, new therapeutic options have emerged within the past 5 years, particularly targeted agents. These agents represent a new era for treatment of GEP-NETs, but also create a key area of educational need, as the new data challenge the current paradigm of patient treatment. These activities review the novel treatment choices for improving care in patients diagnosed with GEP-NETs.

eMedia - Oncology




Physician's Weekly for Current Medical News, Events & Issues